Stop Missing What Matters.
Countable PCR Sees It All.

Translational oncology demands the ability to detect rare variants with confidence, monitor disease with high sensitivity, and generate reliable results from limited samples. Yet many current approaches—qPCR, dPCR, and NGS—struggle to detect ultra-low abundance targets, require complex workflows, or deliver inconsistent results.

Countable PCR changes that.
Learn how Countable PCR enables oncology panels delivering highly sensitive variant detection, down to 0.004%, in a simple, streamlined workflow with reproducible results - giving researchers the confidence to detect what others miss.

Visit our booth to learn more:
April 19-22
Booth #1454

Check our poster presentations:

📊 Poster 2594
Presented in collaboration with LabCorp

🗓️ Monday, April 20 | 9:00 AM - 12:00 PM PST
A Deep Sampling and Single Molecule Digital Counting Assay for Rare Molecule Detection

• Rare variant detection is constrained by dPCR input constraints and partition capacity
• Single molecule digital counting enables ultra-sensitive multiplexed detection of KIT D816V using a single tube workflow and deep sampling
• Strong concordance with dPCR demonstrates high sensitivity and accuracy with a simpler, cost-efficient workflow
• Single molecule counting

📊 Poster 7615
🗓️ Wednesday, April 22 | 9:00 AM - 12:00 PM PST
Multiplex Detection of BCR-ABL1 Fusion Transcripts in a Streamlined Single-Tube Workflow Using PCR-Based Single Molecule Counting

• Simultaneous quantification of three BCR-ABL1 isoforms (p210, p230, p190) in a single tube workflow
• High sensitivity across a broad dynamic range enables accurate detection of rare and abundant transcripts
• Direct molecule counting enables precise, reproducible results without a standard curve